Patient Perspectives on Deprescribing GLP-1 RAs for Obesity Care | Retatrutide News

Patient views on the affordability of GLP-1 receptor agonists for obesity care are being explored. This is significant for Eli Lilly's Retatrutide as it...
Patient Experiences · October 15, 2026